Improving support for young biomedical scientists-Reference-Cited by-同舟云学术

Improving support for young biomedical scientists

Published:2018-05-18 Issue:6390 Volume:360 Page:716-718
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Alberts Bruce¹,Hyman Tony²,Pickett Christopher L.³⁴,Tilghman Shirley⁴,Varmus Harold⁵

Affiliation:

1. University of California, San Francisco, San Francisco, CA, USA.

2. Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

3. American Association for the Advancement of Science, Washington, DC, USA.

4. Lewis-Sigler Institute, Princeton University, Princeton, NJ, USA.

5. Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Abstract

Expand grant programs to encourage innovative research

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference14 articles.

1. A generation at risk: Young investigators and the future of the biomedical workforce

2. T. Hyman A. Desai P. Walter On research funding and the power of youth ASCB Newsletter October 2016; www.ascb.org/newsletter/october-2016-newsletter/october-2016-newsletter-on-research-funding-and-the-power-of-youth/.

3. Opinion: The Next Generation Researchers Initiative at NIH

4. Future of fundamental discovery in US biomedical research

5. Rescuing US biomedical research from its systemic flaws

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Analysis of the Effects of BWF Interdisciplinary Postdoctoral to Faculty Transition Awards on Future Funding Success;2024-07-05

2. Does academic engagement with industry come at a cost for early career scientists? Evidence from high-tech enterprises’ Ph.D. funding programs;Information Processing & Management;2024-05

3. Survey on status quo and development needs of research and innovation capabilities of young researchers at university-affiliated hospitals in China: a cross-sectional survey;Annals of Translational Medicine;2022-09

4. Rethinking Business Model for Drug Discovery, Post-COVID;SSRN Electronic Journal;2022

5. Changes in the National Cancer Institute’s R01 workforce: growth, aging, retention, and policy implications;Journal of Clinical Investigation;2021-04-01